We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
Cap. Flow
-$831M
Cap. Flow %
-1.77%
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$130M
2
AMGN icon
Amgen
AMGN
+$96.1M
3
PGR icon
Progressive
PGR
+$94.9M
4
ABBV icon
AbbVie
ABBV
+$77.1M
5
KVUE icon
Kenvue
KVUE
+$75.6M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$148M
2
JNJ icon
Johnson & Johnson
JNJ
+$147M
3
LYB icon
LyondellBasell Industries
LYB
+$108M
4
DG icon
Dollar General
DG
+$91.2M
5
XOM icon
ExxonMobil
XOM
+$87.6M

Sector Composition

Rank Sector Weight
1 Technology 24.48%
2 Healthcare 17.42%
3 Financials 12.53%
4 Consumer Discretionary 9.71%
5 Communication Services 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRON
1751
DELISTED
Kronos Bio
KRON
$21K ﹤0.01%
16,150
– –
AMWL icon
1752
American Well
AMWL
$185M
$15.7K ﹤0.01%
670
-11
-2% -$372
SYBX
1753
DELISTED
Synlogic
SYBX
$6.2K ﹤0.01%
2,207
– –
DNA.WS
1754
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$3.62K ﹤0.01%
16,100
– –
AVIR icon
1755
Atea Pharmaceuticals
AVIR
$386M
– –
-84,030
Closed -$314K
CPRI icon
1756
Capri Holdings
CPRI
$1.82B
– –
-45,505
Closed -$1.63M
FATE icon
1757
Fate Therapeutics
FATE
$283M
– –
-123,750
Closed -$589K
GMAB icon
1758
Genmab
GMAB
$17.7B
– –
-18,200
Closed -$692K
GOSS icon
1759
Gossamer Bio
GOSS
$97.5M
– –
-1,238,000
Closed -$1.49M
INGN icon
1760
Inogen
INGN
$171M
– –
-28,965
Closed -$335K
RBA icon
1761
RB Global
RBA
$21.7B
– –
-441,821
Closed -$26.5M
SEER icon
1762
Seer Inc
SEER
$108M
– –
-56,740
Closed -$242K
SRDX
1763
DELISTED
Surmodics
SRDX
– –
-11,020
Closed -$345K
TVTX icon
1764
Travere Therapeutics
TVTX
$5.27B
– –
-110,088
Closed -$1.69M
UAL icon
1765
United Airlines
UAL
$39.1B
– –
-234,680
Closed -$12.9M
VTV icon
1766
Vanguard Value ETF
VTV
$189B
– –
-100,000
Closed -$14.2M
XLF icon
1767
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
– –
-447,296
Closed -$15.1M
NBIS
1768
Nebius Group N.V.
NBIS
$47.7B
$0 ﹤0.01%
22,300
– –
TVRD
1769
Tvardi Therapeutics
TVRD
$23.8M
– –
-2,466
Closed -$251K
LSXMA
1770
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
– –
-72,337
Closed -$1.74M
GRTX
1771
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
– –
-151,777
Closed -$474K
AEL
1772
DELISTED
American Equity Investment Life Holding Company
AEL
– –
-20,973
Closed -$1.09M
ROVR
1773
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
– –
-216,051
Closed -$1.06M
VRTV
1774
DELISTED
VERITIV CORPORATION
VRTV
– –
-5,016
Closed -$630K
PACW
1775
DELISTED
PacWest Bancorp
PACW
– –
-48,406
Closed -$395K
68 69 70
71
72

Similar funds

Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
State Board of Administration of Florida Retirement System
State Board of Administration of Florida Retirement System Tallahassee, Florida $53.4B AUM 29.16% 1-Year Est. Return
Betterment LLC
Betterment LLC New York $52.8B AUM 15.34% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SCP
Soroban Capital Partners New York $51.8B AUM 21.41% 1-Year Est. Return

Ensign Peak Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
  • Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
  • Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
  • Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
  • Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
  • Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.

Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.